New Delta+ variant found in India can escape antibodies downtoearth.org.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from downtoearth.org.in Daily Mail and Mail on Sunday newspapers.
ILSF also announced that Biocon founder and Executive Chairperson Kiran Mazumdar-Shaw has contributed Rs 5 crore to the organisation dedicated to funding promising life science research.
Shahid Jameel steps down as chief advisor of govt COVID panel; raises questions [details] ibtimes.co.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ibtimes.co.in Daily Mail and Mail on Sunday newspapers.
India s second COVID-19 wave flattening but won t wane away before July, says Shahid Jameel
Shahid Jameel noted that it is a little too early to say if the Covid wave has peaked
PTI | May 12, 2021 | Updated 13:49 IST
India s second COVID-19 wave seems to have flattened but the climb down will be a more prolonged, long drawn-out process than the first and will possibly run till July, eminent virologist Shahid Jameel said here on Tuesday.
Though the new variants of the virus may partly be responsible for the explosion in the number of cases, there is no indication the mutant versions are more lethal, added the director of the Trivedi School of Biosciences, Ashoka University, amid mounting worries about what is fuelling the second wave in India.
Source:
Highlights
According to the scientist, COVID-19 cases in the second wave also won t come down in as steady a fashion as they did after the first wave
In his view, the actual mortality data for India is completely wrong, not because of some evil design of someone or a group of people or the state or whatever
New Delhi: India s second COVID-19 wave seems to have flattened but the climb down will be a more prolonged, long-drawn-out process than the first and will possibly run till July, says eminent virologist Shahid Jameel.
Though the new variants of the virus may partly be responsible for the explosion in the number of cases, there is no indication the mutant versions are more lethal, added the director of the Trivedi School of Biosciences, Ashoka University, amid mounting worries about what is fuelling the second wave in India.